Cargando…

Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis

BACKGROUND: Vulvovaginal candidiasis (VVC) is an important health problem caused by Candida spp. The aim of this study was molecular identification, phylogenetic analysis, and evaluation of antifungal susceptibility of non-albicans Candida isolates from VVC. METHODS: Vaginal secretion samples were c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nejat, Ziba Abbasi, Farahyar, Shirin, Falahati, Mehraban, Khozani, Mahtab Ashrafi, Hosseini, Aga Fateme, Faiazy, Azamsadat, Ekhtiari, Masoome, Hashemi-Hafshenjani, Saeideh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pasteur Institute 2018
Materias:	Full Length
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712382/ https://www.ncbi.nlm.nih.gov/pubmed/28688376 http://dx.doi.org/10.22034/ibj.22.1.33

Ejemplares similares

The first report of onychomycosis caused by Cryptococcus friedmannii (Naganishia friedmannii) a basidiomycetous yeast
por: Ekhtiari, Masoome, et al.
Publicado: (2017)

Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis
por: Farahyar, Shirin, et al.
Publicado: (2020)

Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis
por: Khosravi Rad, K, et al.
Publicado: (2016)

ALS1 and ALS3 gene expression and biofilm formation in Candida albicans isolated from vulvovaginal candidiasis
por: Roudbarmohammadi, Shahla, et al.
Publicado: (2016)

Does alternation of Candida albicans TUP1 gene expression affect the progress of symptomatic recurrent vulvovaginal candidiasis?
por: Ghazanfari, Mona, et al.
Publicado: (2020)

Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
por: David, Helma, et al.
Publicado: (2023)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
por: Miao, Jian, et al.
Publicado: (2023)

Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995)

New Treatments for Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1996)

Changing Trends of Vulvovaginal Candidiasis
por: Vijaya, Doddaiah, et al.
Publicado: (2014)

Clinicomycological study of vulvovaginal candidiasis
por: Seeniammal, S., et al.
Publicado: (2021)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020)

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)

Clinical and morphopathological assay in vulvovaginal candidiasis
por: Manolea, Maria Magdalena, et al.
Publicado: (2022)

Insights and advances in recurrent vulvovaginal candidiasis
por: San Juan Galán, Javier, et al.
Publicado: (2023)

A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis
por: Liu, Junyan, et al.
Publicado: (2021)

Candida albicans Multilocus Sequence Typing Clade I Contributes to the Clinical Phenotype of Vulvovaginal Candidiasis Patients
por: Zhu, Yuxia, et al.
Publicado: (2022)

Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China
por: Hong, Nan, et al.
Publicado: (2022)

Antibiofilm Activity of Essential Fatty Acids Against Candida albicans from Vulvovaginal Candidiasis and Bloodstream Infections
por: Wang, Shuai, et al.
Publicado: (2022)

Candidiasis vulvovaginal tratamiento oral con itraconazol/
por: Rodriguez Serrano, Tiburcio Manuel
Publicado: (1993)

Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
por: Mahmoudabadi, Ali Zarei, et al.
Publicado: (2013)

Sexual function, depression, anxiety, and vulvovaginal candidiasis
por: Başer, Emre, et al.
Publicado: (2021)

Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis
por: Jaldani, Shirin, et al.
Publicado: (2021)

Differential role of gpaB and sidA gene expressions in relation to virulence in Aspergillus species from patients with invasive aspergillosis
por: Ghods, Nayereh, et al.
Publicado: (2018)

Molecular identification and antifungal susceptibility profile of Candida species isolated from patients with vulvovaginitis in Tehran, Iran
por: Sharifynia, Somayeh, et al.
Publicado: (2017)

Correction to: Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis
por: Jaldani, Shirin, et al.
Publicado: (2021)

Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt
por: Gerges, Marian A, et al.
Publicado: (2023)

Systemic vs. Topical Therapy for the Treatment of Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1994)

Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
por: Woodburn, Kathryn W., et al.
Publicado: (2019)

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
por: Willems, Hubertine M. E., et al.
Publicado: (2020)

Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis
por: Rodríguez-Cerdeira, Carmen, et al.
Publicado: (2020)

Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus
por: Phillips, Nancy A., et al.
Publicado: (2022)

Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis
por: Neal, Chemen M, et al.
Publicado: (2022)

Vulvovaginal Candidiasis in Pregnancy—Between Sensitivity and Resistance to Antimycotics
por: Maftei, Nicoleta-Maricica, et al.
Publicado: (2023)

Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis
por: Zhang, Xu, et al.
Publicado: (2018)

α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans
por: Abe, Masahiro, et al.
Publicado: (2021)

Genotyping of candida albicans isolates obtained from vulvovaginal candidiasis patients in Zanjan, Iran, based on ABC and RPS typing systems
por: Amanloo, Saeid, et al.
Publicado: (2022)

The Recurrent Vulvovaginal Candidiasis: Proposal of a Personalized Therapeutic Protocol
por: Murina, F., et al.
Publicado: (2011)

Practices of Lebanese gynecologists regarding treatment of recurrent vulvovaginal candidiasis
por: Adib, Salim M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t9gn9ooee5rp7vfp9hqu83l49q